News | August 12, 2022
Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
This next-generation bivalent COVID-19 vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain (wild-type) and an Omicron variant.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Medicfibers in collaboration with AIIMS New Delhi, has developed an antimicrobial solution Viroclog that when applied as a coating on textiles, provides long-lasting protection against HAI by reducing virus, bacteria, fungi survival on fabric
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Subscribe To Our Newsletter & Stay Updated
